Literature DB >> 23619718

Genome-wide association study signal at the 12q12 locus for Crohn's disease may represent associations with the MUC19 gene.

Vijay Kumar1, David R Mack, Valerie Marcil, David Israel, Alfreda Krupoves, Irina Costea, Philippe Lambrette, Guy Grimard, Jinsong Dong, Ernest G Seidman, Devendra K Amre, Emile Levy.   

Abstract

BACKGROUND: Genome-wide association studies (GWAS) in Crohn's disease (CD) have identified associations with single-nucleotide polymorphism (SNP) rs11175593 at chromosome 12q12. The MUC19 and LRRK2 genes reside close to the GWAS signal, but it is as yet unclear which of the 2 genes represent the CD susceptibility genes.
METHODS: We studied associations between nonsynonymous coding variants in the MUC19 (5) and LRRK2 (3) genes in a case-control sample comprising CD cases aged <18 years at diagnosis. The GWAS lead SNP rs11175593 was also investigated. Allelic, genotype, and haplotype associations were examined assuming different models of inheritance.
RESULTS: A total of 530 cases and 600 controls were studied. The mean (±SD) age at diagnosis was 12.4 (±3.3). Most cases were male (57.4%). Most patients had ileocolonic disease location (48.8%) and inflammatory behavior at diagnosis (87.0%). Three MUC19 SNPs were nominally significantly associated with CD (rs11564245, AspHis: P = 0.02; rs4768261, SerPhe: P = 0.0008; and rs2933353, GluAla: P = 0.01). Associations with rs4768261 were maintained after corrections for multiple comparisons (permuted, P = 0.007). None of the LRRK2 SNPs were associated with CD. Haplotype analysis supported the single SNP associations noted with the MUC19 gene.
CONCLUSIONS: GWAS signal at chromosome 12q12 for CD may represent associations with the MUC19 gene.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23619718     DOI: 10.1097/MIB.0b013e318281f454

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  9 in total

Review 1.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 2.  Genetic variants of mucins: unexplored conundrum.

Authors:  Sushil Kumar; Eric Cruz; Suhasini Joshi; Asish Patel; Rahat Jahan; Surinder K Batra; Maneesh Jain
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

3.  Salivary mucin 19 glycoproteins: innate immune functions in Streptococcus mutans-induced caries in mice and evidence for expression in human saliva.

Authors:  David J Culp; Bently Robinson; Melanie N Cash; Indraneel Bhattacharyya; Carol Stewart; Giancarlo Cuadra-Saenz
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

4.  In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.

Authors:  Jill Skepner; Mark Trocha; Radha Ramesh; Xiaoyan A Qu; Darby Schmidt; Erkan Baloglu; Mercedes Lobera; Scott Davis; Michael A Nolan; Thaddeus J Carlson; Jonathan Hill; Shomir Ghosh; Mark S Sundrud; Jianfei Yang
Journal:  Immunology       Date:  2015-04-03       Impact factor: 7.397

5.  IBD candidate genes and intestinal barrier regulation.

Authors:  Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

Review 6.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

7.  Signatures within the esophageal microbiome are associated with host genetics, age, and disease.

Authors:  Nandan P Deshpande; Stephen M Riordan; Natalia Castaño-Rodríguez; Marc R Wilkins; Nadeem O Kaakoush
Journal:  Microbiome       Date:  2018-12-17       Impact factor: 14.650

8.  Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.

Authors:  Francesco Longo; Isabella Russo; Derya R Shimshek; Elisa Greggio; Michele Morari
Journal:  Neurobiol Dis       Date:  2014-08-06       Impact factor: 5.996

Review 9.  LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.

Authors:  Daniel C Berwick; George R Heaton; Sonia Azeggagh; Kirsten Harvey
Journal:  Mol Neurodegener       Date:  2019-12-21       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.